Subsequent studies are needed to demonstrate if FOXP3 regulatory T cells inhibit regression in melanoma, as part of the immunogenic effect of melanoma cells, or if the lack of FOXP3-positive cells is the result of regression. The gene discussed is FOXP3; the disease is melanoma.